Clearance by the liver in cirrhosis. III. Propranolol uptake by the isolated perfused human liver

Canadian Journal of Physiology and Pharmacology

Volumn 74, Issue 12, 1996, Pages 1327-1332

  Villeneuve, Jean Pierre ^a,b   Dagenais, Michel ^a   Huet, P Michel ^a   Lapointe, Réal ^a   Roy, André ^a   Marleau, Denis ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITY OF MONTREAL   (Canada)

Author keywords

Cirrhosis; Clearance; Hepatic microcirculation; Propranolol

Indexed keywords

PROPRANOLOL;

ARTICLE; CONTROLLED STUDY; DILUTION; DRUG DETERMINATION; DRUG UPTAKE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; IN VITRO STUDY; ISOTOPE LABELING; LIVER CIRRHOSIS; LIVER CLEARANCE; METABOLIC CAPACITY; PRIORITY JOURNAL; STEADY STATE;

EID: 0030435509     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/y96-148     Document Type: Article

References (23)

1. Burczynski, F.J., and Luxon, B.A. 1995. Is there facilitated uptake of fatty acids by the liver? Interpretation and analysis of experimental data. Can. J. Physiol. Pharmacol. 73: 409-420.
2. Burczynski, F.J., Moran, J.B., and Cai, Z.S. 1993. Facilitated dissociation of albumin - fatty acid complexes by rat hepatocytes. J. Pharmacol. Exp. Ther. 267: 714-719.
3. Fenyves, D., Gariépy, L., and Villeneuve, J.P. 1993. Clearance by the liver in cirrhosis. I. Relationship between propranolol metabolism in vitro and its extraction by the perfused liver in the rat. Hepatology, 17: 301-306.
4. Forker, E.L., and Luxon, B.A. 1981. Albumin helps mediate removal of taurocholate by rat liver. J. Clin. Invest. 67: 1517-1522.
5. Gariépy, L., Fenyves, D., Petit, J.L., Raymond, G., and Villeneuve, J.P. 1990. Propranolol metabolism by isolated hepatocytes from normal and cirrhotic rat livers: the effect of albumin. Can. J. Physiol. Pharmacol. 68: 657-662.
6. Gariépy, L., Fenyves, D., and Villeneuve, J.P. 1992. Propranolol disposition in the rat: variation in hepatic extraction with unbound drug fraction. J. Pharm. Sci. 81: 255-258.
7. Gariépy, L., Fenyves, D., Kassissia, I., and Villeneuve, J.P. 1993. Clearance by the liver in cirrhosis. II. Characterization of propranolol uptake with the multiple indicator dilution technique. Hepatology, 18: 823-831.
8. Gartner, U., Stockert, R.J., Levine, W.G., and Wolkoff, A.W. 1982. Effect of nafenopin on the uptake of bilirubin and sulfobromophthalein by the isolated perfused rat liver. Gastroenterology, 83: 1163-1169.
9. Goresky, C.A. 1963. A linear method for determining liver sinusoidal and extravascular volume. Am. J. Physiol. 204: 626-640.
10. Goresky, C.A., Bach, G.G., and Nadeau, B.E. 1973. On the uptake of materials by the intact liver. The transport and net removal of galactose. J. Clin. Invest. 52: 991-1009.
11. Keiding, S., Ott, P., and Bass, L. 1993. Enhancement of unbound clearance of ICG by plasma proteins, demonstrated in human subjects and interpreted without assumption of facilitating structures. J. Hepatol. 19: 327-344.
12. Kornhauser, D.M., Wood, A.J.J., Vestal, R.E., Wilkinson, G.R., Branch, R.A., and Shand, D.G. 1978. Biological determinants of propranolol disposition in man. Clin. Pharmacol. Ther. 23: 165-174.
13. Miyauchi, S., Sawada, Y., Iga, T., Hanano, M., and Sugiyama, Y. 1993. Comparison of the hepatic uptake clearances of fifteen drugs with wide range of membrane permeabilities in isolated rat hepatocytes and perfused rat livers. Pharm. Res. (N.Y.), 10: 434-440.
14. Mizuma, T., Horie, T., and Awazu, S. 1985. The effect of albumin on the uptake of bromosulfophthalein. J. Pharmacobio-Dyn. 8: 90-94.
15. Pessayre, D., Lebrec, D., Descatoire, V., Peignoux, M., and Benhamou, J.P. 1978. Mechanism for reduced drug clearance in patients with cirrhosis. Gastroenterology, 74: 566-571.
16. Popper, H., Elias, H., and Petty, D.E. 1952. Vascular pattern of the cirrhotic liver. Am. J. Clin. Pathol. 22: 717-729.
17. Schaffner, F., and Popper, H. 1963. Capillarization of hepatic sinusoids. Gastroenterology, 44: 239-242.
18. Schneck, D.W., Pritchard, J.F., and Hayes, A.H. 1977. Studies on the uptake and binding of propranolol by rat tissues. J. Pharmacol. Exp. Ther. 203: 621-629.
19. Shand, D.G., Nickolls, E.M., and Oates, J.A. 1970. Plasma propranolol levels in adults with observations in four children. Clin. Pharmacol. Ther. 11: 112-120.
20. Villeneuve, J.P., Huet, P.M., Gariépy, L., Fenyves, D., Willems, B., Côté, J., Lapointe, R., and Marleau, D. 1990. Isolated perfused cirrhotic human liver obtained from liver transplant patients: a feasibility study. Hepatology, 12: 257-263.
21. Villeneuve, J.P., Dagenais, M., Huet, P.M., Roy, A., Lapointe, R., and Marleau, D. 1996. The hepatic microcirculation in the isolated perfused human liver. Hepatology, 23: 24-31.
22. Wisse, E., DeZanger, R.B., Charels, K., Van Der Smissen, P., and McCuskey, R.S. 1985. The liver sieve: considerations concerning the structure and function of endothelial fenestrae, the sinusoidal wall and the space of Disse. Hepatology, 5: 683-692.
23. Wood, A.J.J., Carr, K., Vestal, R.E., Belcher, S., Wilkinson, G.R., and Shand, D.G. 1978. Direct measurement of propranolol bioavailability during accumulation to steady-state. Br. J. Clin. Pharmacol. 6: 345-350.